Treatment for Glaucoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Glaucoma
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new procedure to lower eye pressure in people with early to moderate stage primary open-angle glaucoma who are also having cataract surgery.

Eligible Conditions
  • Glaucoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

2
Low Energy SLT
2
XEN45 (Glaucoma Gel Stent)
1
CyPass Micro-Stent

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 24 Month

24 Month
Mean Change in medication-free DIOP from baseline
Proportion of subjects who achieve a decrease in medication-free mean diurnal IOP (DIOP) from baseline of at least 20%

Trial Safety

Safety Progress

1 of 3

Similar Trials

3
Low Energy SLT
3
XEN45 (Glaucoma Gel Stent)
1
CyPass Micro-Stent

Trial Design

0 Treatment Group

318 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 month

Who is running the clinical trial?

Elios Vision, Inc.Lead Sponsor
ELT Sight, IncLead Sponsor
Iqbal (Ike) Ahmed, MDStudy DirectorPrism Eye Institute

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
IOP of 22 to 34 mmHg.
You have a diagnosis of mild to moderate POAG.
You have a cataract and a BCVA of 20/40 or worse.

Who else is applying?

What state do they live in?
California100.0%
How old are they?
65+100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top